Cinacalcet Tablet, Film Coated
Product Images NDC 65862-831

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cinacalcet (NDC 65862-831). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Mean (se) Ipth Values (pooled Phase 3 Studies) (Cinacalcet Fig1)

FDA Label Image

Figure 2. Mean (se) Ca X P Values (pooled Phase 3 Studies) (Cinacalcet Fig2)

FDA Label Image

Figure 3 (Cinacalcet Fig3)

FDA Label Image

Figure 4. Mean Serum Calcium (se) At Baseline, End Of Titration, And Scheduled Maintenance Visits (patients With Severe Intractable Primary Hpt) (Cinacalcet Fig4)

FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
Cinacalcet Tablets are a prescription medication containing Cinacalcet Hydrochloride, equivalent to 30mg of cinacalcet per film-coated tablet. The usual dosage instructions can be found in the package insert. The medication should be stored in a tightly sealed, light-resistant container at a temperature of 20°C to 25°C. The manufacturer is Aurobindo Pharma USA, Inc., and the product was made in India. The text appears to end with some coding information.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
Each tablet of Cinacalce Hydrochloride 6 mg contains an equivalent to Cinacalvet 60 mg. This medicine is distributed by Aurobindo Pharma USA, Inc. and made in India. The usual dosage is mentioned in the package insert, and it is a prescription drug with controlled room temperature requirements. The description includes an NDC number, and each package contains 30 tablets. The text mentions instructions for dispensing these tablets into a tight, light-resistant container as per USP guidelines. The last line indicates an over-printing zone coding area of 4515 mm.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
Cinacalcet Tablets is a prescription drug with the NDC code 65862-833-30. Each bottle contains 30 tablets manufactured by Aurobindo Pharma USA, Inc. The drug is composed of Ginacalost Hydrochloride, which is an equivalent to 90 mg of cinacalcet. The package insert should be consulted for usual dosage, while storage requirements require a temperature of 20°C to 25°C. Dispensation should be done in a tightly sealed, opaque container per USP.*
FDA Label Image

Chemical Structure (Cinacalcet Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.